Inhalation Sciences Sweden AB
The answer first
Does Inhalation Sciences Sweden beat the market?
No, Inhalation Sciences Sweden has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 82% of Nordic stocks
- Quality99
- Value100
- Trend1
No. 23 of 195 in healthcare
Max for seven days
Follow Inhalation Sciences Sweden with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 17 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Inhalation Sciences Sweden
Your first answer is free, no account needed.
Do you own Inhalation Sciences Sweden, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Inhalation Sciences Sweden and a few more. Free, no card.
Super Stock+45.1%In short
- Inhalation Sciences Sweden has fallen 87.6% over the past year, including dividends.
- Overall, Inhalation Sciences Sweden ranks better than 82% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 99.0%. The price is 99.6% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 82% of Nordic stocks.
No. 23 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 6 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns1.03
- Return on equityProfit divided by equity−135.6%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
High Low price: you pay little for what the company earns and owns.
No. 2 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.4
- P/SPrice divided by sales0.3
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 192 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−66.9%
- 6 months−81.4%
- 9 months−80.2%
- 12 months−87.6%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Inhalation Sciences Sweden
Inhalation Sciences Sweden AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 5 employees.
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an un…


See the full analysis of Inhalation Sciences Sweden.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card